For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230510:nRSJ8559Ya&default-theme=true
RNS Number : 8559Y Spirax-Sarco Engineering PLC 10 May 2023
News Release
10(th) May 2023
AGM trading update
Trading in line with expectations; full year guidance maintained
Economic environment
Following global Industrial Production growth(1) (IP) of 2.8% in 2022, IP was
0.6% in the first quarter of 2023 against a backdrop of continuing uncertainty
over the global macroeconomic outlook. IP is expected to strengthen modestly
by the end of the year, with full year 2023 IP now forecasted to be 1.3%.
Trading
Organic sales growth in the four months to the end of April was in line with
our expectations, driven by growth significantly above IP in Steam Specialties
and Electric Thermal Solutions (ETS). Watson-Marlow sales were lower compared
to the same period of 2022, as anticipated, reflecting the ongoing
normalisation of COVID-19 related demand from Biotechnology &
Pharmaceutical customers.
Order books in Steam Specialties and ETS remain at historically high levels
driven by strong demand. Watson-Marlow's monthly order intake has remained
at a level similar to the fourth quarter of 2022. As the underlying demand
for cell and gene therapy medications remains strong, we continue to
anticipate an increase in order intake in the second half of the year once
Biotechnology & Pharmaceutical customers have worked through their excess
stocks. However, defining the precise timing and initial pace of this return
to growth remains difficult.
Integration of the acquisitions of Vulcanic and Durex Industries is
progressing well, supported by revenue investments to raise the operations to
our standards and deliver future growth.
As expected, the Group adjusted operating profit margin in the first four
months of the year was lower than the same period in 2022. Consistent with
the strong sales performance in Steam Specialties and ETS, both Businesses
delivered increased margins, while Watson-Marlow's margin was lower due to the
operational gearing effect of reduced sales.
We still anticipate Watson-Marlow's adjusted operating profit margin and
therefore the Group's margin, will recover in the second half of the year,
driven by expected higher demand and the full benefit from actions taken in
the first quarter to right-size Watson-Marlow capacity and overhead support
costs.
Currency movements had a small positive effect on sales and operating profit,
compared to the same period of 2022. If current exchange rates were to
prevail for the remainder of the year, we anticipate a modest adverse effect
on full year sales and profit, compared with the full year 2022.
Financial Position
Excluding leases, net debt at 30th April 2023 was £710 million, up from £690
million at 31st December 2022. The final dividend of 109.5 pence per share, a
12% increase over prior year, will be paid on 19th May 2023, subject to
shareholder approval, with a cash impact of £81 million.
We anticipate cash conversion will improve in 2023 to above 70%, including
capital expenditure at approximately 7% of sales.
Outlook
Although the global macroeconomic outlook remains uncertain, forecast IP for
2023 of 1.3% remains within the range of our planning assumptions. As our
trading in the first four months of the year is also in line with our
expectations, we are maintaining our full year guidance for the Group.
We continue to anticipate double-digit sales growth for the Group in 2023,
representing mid-single-digit sales growth over 2022 pro-forma sales(2). We
also continue to anticipate both sales and adjusted operating profit to be
more weighted to the second half of the year than in previous years, with a
small progression in the Group's full year adjusted operating profit
margin.
(1) Source for Industrial Production data: Oxford Economics, 25th April 2023
(2) Group Sales in 2022 pro-forma for the twelve-month contribution from the
acquisitions of Vulcanic and Durex Industries
Spirax-Sarco Engineering plc expects to publish its 2023 Half Year results on
10th August 2023.
Enquiries:
For further information, please contact:
Nimesh Patel, Chief Financial Officer
Mal Patel, Head of Investor Relations
Tel: +44 7392 263166
About Spirax‐Sarco Engineering plc
Spirax‐Sarco Engineering plc is a thermal energy management and niche
pumping specialist. It comprises three world‐leading Businesses: Steam
Specialties, for the control and management of steam; Electric Thermal
Solutions, for advanced electrical process heating and temperature management
solutions; and Watson-Marlow, for peristaltic pumping and associated fluid
path technologies. The Steam Specialties and Electric Thermal Solutions
Businesses provide a broad range of fluid control and process heating
products, engineered packages, site services and systems expertise for a
diverse range of industrial and institutional customers. Both businesses
help their customers improve process efficiencies, meet environmental
sustainability targets, improve product quality and enhance the safety of
their operations. Watson‐Marlow provides solutions for a wide variety of
demanding fluid path applications with highly accurate, controllable and
virtually maintenance-free pumps and associated technologies.
The Group is headquartered in Cheltenham (UK), has 40 strategically located
manufacturing plants around the world and employs more than 10,400 people,
including more than 2,100 direct sales and service engineers. The Company's
shares have been listed on the London Stock Exchange since 1959 (symbol: SPX)
and it is a constituent of the FTSE 100 and the FTSE4Good Indexes.
Further information can be found at www.spiraxsarcoengineering.com
(http://www.spiraxsarcoengineering.com)
RNS filter: Inside information prior to release
LEI 213800WFVZQMHOZP2W17
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END TSTBRGDUDXGDGXC